Literature DB >> 29305664

Effect of Formulation and Process Parameters on the Disproportionation of Indomethacin Sodium in Buffered Lyophilized Formulations.

Sampada Koranne1, Seema Thakral1, Raj Suryanarayanan2.   

Abstract

PURPOSE: (i) To investigate buffer salt crystallization and the consequent pH shifts during the freezing stage of the lyophilization of indomethacin sodium (IMCNa) in aqueous sodium phosphate buffer. (ii) To determine the effect of pH shift on the disproportionation of IMCNa in lyophilized formulations.
METHODS: Prelyophilization solutions containing IMCNa in sodium phosphate buffer, at initial buffer concentrations ranging from 10 to 100 mM (pH 7.0), and at IMCNa concentrations of 5, 10 & 15 mg/ml, were investigated. Their phase behavior during cooling was monitored by low temperature X- ray diffractometry (XRD), differential scanning calorimetry (DSC) and pH measurements. The final lyophiles were characterized by infrared spectroscopy (IR) and XRD.
RESULTS: Upon cooling to -25°C, pronounced pH shifts were observed only in IMCNa buffered solutions containing high initial buffer concentration (100 mM), due to crystallization of Na2HPO4. 12H2O. In the final lyophiles, disproportionation of IMCNa to the free acid (IMC) was observed in systems with buffer concentrations ≥50 mM, but not low buffer concentration (10 mM). At intermediate buffer concentrations (35 & 20 mM) the disproportionation depended on IMCNa concentration. The initial concentrations of both buffer and IMCNa influenced the buffer crystallization.
CONCLUSIONS: During freeze drying, selective crystallization of a buffer component and the consequent pH shift can cause disproportionation of IMCNa. This can prolong the reconstitution time or retain particles of the poorly soluble free acid in the reconstituted solution.

Entities:  

Keywords:  buffer crystallization; lyophilization; pH shift; salt disproportionation; salt stability

Mesh:

Substances:

Year:  2018        PMID: 29305664     DOI: 10.1007/s11095-017-2310-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  34 in total

1.  Investigation of Spatial Heterogeneity of Salt Disproportionation in Tablets by Synchrotron X-ray Diffractometry.

Authors:  Sampada Koranne; Ramprakash Govindarajan; Raj Suryanarayanan
Journal:  Mol Pharm       Date:  2017-03-02       Impact factor: 4.939

2.  Weighing benefits and risks--the FDA's review of prasugrel.

Authors:  Ellis F Unger
Journal:  N Engl J Med       Date:  2009-09-03       Impact factor: 91.245

3.  Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant.

Authors:  B R Rohrs; T J Thamann; P Gao; D J Stelzer; M S Bergren; R S Chao
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

4.  Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry.

Authors:  M P te Booy; R A de Ruiter; A L de Meere
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

5.  Lyophilized formulations of recombinant tumor necrosis factor.

Authors:  M S Hora; R K Rana; F W Smith
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

6.  [Use of meglumine indomethacin in the treatment of pain due to neoplastic diseases].

Authors:  S De Marzi; V Morini
Journal:  Clin Ter       Date:  1972-07-19

7.  Solute crystallization in frozen systems-use of synchrotron radiation to improve sensitivity.

Authors:  Dushyant B Varshney; Satyendra Kumar; Evgenyi Y Shalaev; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

8.  Effect of initial buffer composition on pH changes during far-from-equilibrium freezing of sodium phosphate buffer solutions.

Authors:  G Gómez; M J Pikal; N Rodríguez-Hornedo
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

9.  Solid-state characteristics of amorphous sodium indomethacin relative to its free acid.

Authors:  P Tong; G Zografi
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

10.  Root cause evaluation of particulates in the lyophilized indomethacin sodium trihydrate plug for parenteral administration.

Authors:  Akhtar Siddiqui; Ziyaur Rahman; Saeed R Khan; David Awotwe-Otoo; Mansoor A Khan
Journal:  Int J Pharm       Date:  2014-07-30       Impact factor: 5.875

View more
  3 in total

1.  Formulation and Manufacturing of Solid Dosage Forms.

Authors:  Qi Tony Zhou; Tonglei Li
Journal:  Pharm Res       Date:  2018-11-27       Impact factor: 4.200

2.  Low- versus Mid-frequency Raman Spectroscopy for in Situ Analysis of Crystallization in Slurries.

Authors:  Jaana Koskela; Joshua J Sutton; Tiina Lipiäinen; Keith C Gordon; Clare J Strachan; Sara J Fraser-Miller
Journal:  Mol Pharm       Date:  2022-05-03       Impact factor: 5.364

3.  Surface Stabilization and Dissolution Rate Improvement of Amorphous Compacts with Thin Polymer Coatings: Can We Have It All?

Authors:  Dunja Novakovic; Leena Peltonen; Antti Isomäki; Sara J Fraser-Miller; Line Hagner Nielsen; Timo Laaksonen; Clare J Strachan
Journal:  Mol Pharm       Date:  2020-02-25       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.